Acute Pulmonary Embolism — 2026 AHA/ACC Guidelines: What Really Changes

3 AM, rapid response vehicle. 52-year-old woman, sudden dyspnea for one hour, SpO2 88%, tachycardia 118 bpm, BP 95/60. Chest examination almost silent. ECG shows sinus tachycardia with T-wave inversion in V1–V4. No crackles, no obvious bronchospasm.

Your colleague suggests "COPD exacerbation." You're thinking pulmonary embolism. But how do you prove it in the ambulance? You can't. But you can do something much more useful: suspect it the right way, collect the right data, and communicate it the right way.

And that's exactly the message of the new 2026 guidelines.

The first AHA/ACC guidelines dedicated to acute PE

In February 2026, the American Heart Association and the American College of Cardiology — together with eight other scientific societies including ACEP (American College of Emergency Physicians) — published the first joint guideline specifically dedicated to the evaluation and management of acute pulmonary embolism in adults.

Not an update, not a focused update: a de novo document, comprehensive, starting from clinical presentation and extending to follow-up, covering diagnosis, stratification, therapy, and multidisciplinary management.

The baseline epidemiological data is sobering: approximately 470,000 hospitalizations for PE per year in the United States alone, with mortality reaching 1 in 5 in high-risk patients. The guideline's message is clear: timely diagnosis and appropriate treatment are determinants of outcome — and this pathway begins well before CTPA.

For those working in EMS and ED, this guideline is not "yet another 200-page document from cardiologists." It's an operational framework that directly concerns us, because it redefines the language we use to discuss severity, the criteria by which we decide the care setting, and the role of multidisciplinary teams in managing intermediate and severe forms.

The major innovation: clinical categories A–E

The heart of the guideline is the introduction of Acute Pulmonary Embolism Clinical Categories, a 5-category system (A–E) with subcategories that replaces — or rather, refines — the previous "low/intermediate/high risk" classification.

Here's the basic logic:

Category A — Subclinical. PE discovered incidentally (e.g., CT for another reason) in an asymptomatic patient. The guideline indicates that these patients can be safely discharged from the ED without admission.

Category B — Symptomatic / low clinical severity. Symptomatic patient but with low clinical severity score (sPESI 0 or equivalent), without right ventricular dysfunction or elevated biomarkers. Candidate for early discharge or outpatient management.

Category C — High clinical severity. Symptomatic patient with high score, possible right ventricular dysfunction and/or elevated biomarkers (troponin, BNP/NT-proBNP). Includes subcategories C1 (without RV dysfunction) and C2 (with RV dysfunction and/or positive biomarkers). Requires admission.

Category D — Incipient cardiopulmonary failure. The patient is not yet in frank shock but shows signs of imminent hemodynamic deterioration: progressive tachycardia, borderline hypotension, worsening oxygenation. Subcategories D1 and D2, with indication for advanced therapies in selected cases.

Category E — Overt cardiopulmonary failure. Persistent hypotension (SBP <90 mmHg) or shock. Subcategory E1 (without cardiac arrest) and E2 (cardiac arrest). Indication for advanced therapies: systemic thrombolysis, catheter-directed thrombolysis, mechanical thrombectomy, surgical embolectomy.

What changes for EMS?

In the prehospital setting, you don't really assign a letter A–E — you lack troponin, structured echo, CTPA. But this system changes the way you think about and communicate the patient:

• It's no longer enough to say "stable" or "unstable": the normotensive but tachycardic, dyspneic patient with worsening hypoxia could be a Category D — and if you don't recognize it, you lose the window for early intervention.
• Your goal in the field is to identify whether the clinical profile is compatible with a category ≥ C, i.e., a non-low-risk PE, and communicate it with structured data to the ED.

What changes for the ED?

The categories provide a direct decision-making framework: the Category determines the setting (discharge vs ward vs intensive care), the type of anticoagulation, and possible escalation to advanced therapies. For the emergency physician, this means having a shared language with cardiologists, pulmonologists, interventional radiologists, and surgeons — especially in the context of PERT (Pulmonary Embolism Response Team), which the guideline recommends.

The real bottleneck for EMS: diagnostic suspicion, not risk score

The challenge in the ambulance is not choosing the anticoagulant or deciding on discharge: it's thinking about PE in the right patient and activating a rapid pathway.

PE is among the most insidious time-dependent diagnoses precisely because it masquerades: dyspnea that looks like COPD, chest pain that looks like ACS, syncope that looks vasovagal, hypotension that looks like sepsis. And the "classic" textbook patient — young postoperative woman with pleuritic pain and hemoptysis — is the exception, not the rule.

The guideline explicitly recognizes this: pre-test probability is the starting point of the diagnostic pathway. And this probability is built with history, risk factors, and clinical presentation — all elements available in the prehospital setting.

Structured approach in 6 moves: the "PE-Alert" for EMS

What follows is a proposed operational pathway for EMS teams, consistent with the AHA principle of timely diagnosis and treatment. It's not a validated protocol — it's a framework to standardize suspicion and accelerate the in-hospital pathway.

Move 1 — When to activate suspicion

Think about PE when you encounter one of these scenarios:

• Unexplained acute dyspnea, with or without pleuritic chest pain — especially if the pulmonary examination is "too clean" relative to the severity of the presentation
• Syncope or presyncope associated with dyspnea or tachycardia
• Disproportionate hypoxia relative to the auscultatory and clinical pattern
• Shock or hypotension without an obvious cause (cardiogenic, hypovolemic, septic)

Move 2 — Anamnestic red flags (30 seconds)

Quickly collect the prothrombotic factors that the guideline lists among the main risk factors: recent or prolonged immobility, surgery in the last 30 days, active malignancy, previous VTE, estrogen therapy (including oral contraception), pregnancy or puerperium, trauma, inflammatory disease, known thrombophilia.

These factors don't make the diagnosis, but they support the pre-test probability — and the guideline is clear: the diagnostic pathway must be guided by clinical probability.

Move 3 — Pre-test probability estimation (Wells, Geneva, PERC)

Here it's essential to distinguish between probability scores (= how likely is it to be PE) and prognostic scores (= if it's PE, how severe is it). In the ambulance you need the first.

• Wells (or simplified Wells): the most widespread, rapid, also includes the subjective clinical component ("alternative diagnosis less likely than PE"). Score ≥2 (simplified) or ≥5 (original) = at least intermediate probability.
• Revised Geneva (or simplified version): more "objective," based only on measurable variables — useful for reducing variability between operators and in systems where nurses or technicians operate.
• PERC (Pulmonary Embolism Rule-out Criteria): only serves to rule out PE in patients already judged to have low clinical probability. If all 8 criteria are negative, the probability of PE is <2% and no further investigations are needed. If even one is positive, you can't rule out anything.

EMS operational rule: if Wells or Geneva indicate at least intermediate probability, or PERC is not applicable/not negative in a patient you've assessed as low-risk, the message to the ED is "PE to be ruled out with priority."

Move 4 — 12-lead ECG: not diagnostic, but orienting

The ECG neither confirms nor rules out PE, but some patterns can strengthen suspicion and especially guide the ED clinician:

• Sinus tachycardia (the most frequent sign, and also the most nonspecific)
• Signs of right strain: T-wave inversion in V1–V4, S1Q3T3 pattern, right axis deviation

• New-onset right bundle branch block (RBBB)
• Supraventricular tachycardia

The ECG also has a differential value: ruling out (or suspecting) STEMI in a hypotensive patient with chest pain is crucial for destination. And an ECG with "right strain" transmitted in advance to the ED completely changes the receiving team's preparation.

Move 5 — POCUS: look for signs of right overload (if available)

Where organization allows — rapid response vehicle, nurse with advanced ultrasound skills, physician — prehospital POCUS can be decisive in severe forms:

• Dilated RV (RV/LV ratio > 1 in apical 4-chamber view)
• Hypokinesis of the RV free wall (McConnell's sign)
• Dilated and non-collapsible inferior vena cava

These signs don't diagnose PE, but in a compatible clinical context they significantly increase probability and especially can prevent pathway errors (e.g., treating as left heart failure what is acute right heart failure).

Move 6 — "PE-Alert" pre-notification to the ED

If suspicion is significant, the call to the ED should be structured and contain elements already ready to activate the diagnostic-therapeutic pathway:

PE-ALERT — Communication template

• Age, sex
• Key symptoms and timing (dyspnea / syncope / chest pain / hemoptysis)
• Vital signs: SpO2 (on room air and with O2), HR, SBP, RR, mental status
• Score: Wells or Geneva (value or category); PERC applicable yes/no
• ECG: presence of right strain signs yes/no
• POCUS (if performed): RV > LV yes/no, dilated IVC yes/no
• Ongoing anticoagulation / known bleeding risk
• ETA and need for resuscitative support

This type of structured pre-alert is the operational translation of the guideline's emphasis on timeliness: every minute gained in communication is a minute gained until CTPA, anticoagulation, or PERT activation.

And in the Emergency Department? ED implications of the new recommendations

The guideline is not just for cardiologists and pulmonologists — the emergency physician is the first clinician who stratifies, decides, and acts. Here are the most relevant recommendations for the ED.

Diagnostic pathway: pre-test probability at the center

The guideline recommends a diagnostic approach guided by probability. In practice:

• Low or intermediate probability (<50%): D-dimer as first step. If negative (with age-adjusted threshold), PE ruled out without imaging.
• High probability (>50%) or positive D-dimer: CTPA (pulmonary CT angiography) as first-choice imaging. V/Q scintigraphy reserved for those who cannot receive contrast medium.

The message for the ED is: don't send everyone to CT. D-dimer, used in the right context (low-intermediate probability), is a powerful exclusion tool that reduces radiation exposure, costs, and overdiagnosis.

Anticoagulation: DOAC > VKA, LMWH > UFH

The recommendations on anticoagulant therapy are clear:

• Initial parenteral anticoagulation: low molecular weight heparin (LMWH) recommended over unfractionated heparin (UFH) in patients with acute PE. UFH remains indicated in cases where advanced therapies or interventional procedures are anticipated, or in the presence of severe renal insufficiency.
• Oral anticoagulation: direct oral anticoagulants (DOACs) are recommended over vitamin K antagonists (VKA, i.e., warfarin) in eligible patients, to reduce the risk of recurrent VTE and major bleeding. DOACs are not recommended in pregnancy.
• Duration: continuation of anticoagulation beyond the initial 3–6 months in patients with first episode of PE without major reversible risk factor, or with persistent risk factor.

Advanced therapies: who, when, how

For the most severe categories (D–E), the guideline stratifies the options:

• Systemic thrombolysis: considered reasonable for patients in Category E1 (cardiopulmonary failure with persistent hypotension without cardiac arrest).
• Mechanical thrombectomy (MT): Class 2a recommendation for high-risk PE (Category E1), Class 2b for intermediate-high risk (D1–D2). Not recommended (Class 3) in low-risk categories (A–C1). May be preferred over systemic thrombolysis when bleeding risk is high.
• Catheter-directed thrombolysis and surgical embolectomy: options for selected patients in categories D and E, based on local resources and available expertise.

PERT: the multidisciplinary team that accelerates decisions

The guideline recommends implementation of Pulmonary Embolism Response Teams (PERT) where resources allow. These multidisciplinary teams — which may include emergency physicians, cardiologists, pulmonologists, interventional radiologists, cardiac surgeons, pharmacists, and specialized nurses — serve to:

• Accelerate risk stratification in intermediate categories (C–D), which are the most complex
• Guide selection of advanced therapies when evidence is limited
• Improve outcomes through shared and timely decision-making
• Reduce treatment variability between operators and centers

The PERT Consortium now counts over 100 medical centers. For EDs that don't have a formal PERT, the guideline emphasizes the need for inter-hospital transfer protocols to centers with advanced resources for patients in categories D–E.

Structured follow-up: the ED's role doesn't end at discharge

The guideline recommends structured follow-up for all patients with PE:

• Clinical contact or visit within 1 week of discharge
• Reassessment at 3 months to decide duration of anticoagulation
• Screening for chronic thromboembolic disease (CTEPD/CTEPH) at each visit for at least 1 year

For the emergency physician, this means that early discharge (Categories A–B) is safe only if embedded in a guaranteed follow-up pathway. Discharging without a safety net is not early discharge: it's undertriage.

Where sPESI fits in — and why it's not the main tool in the ambulance

A clarification worth making, because it generates confusion:

sPESI (simplified Pulmonary Embolism Severity Index), PESI, and Hestia are tools for prognostic stratification and care setting decision. They serve to answer the question "can this patient with confirmed PE be managed at home or is admission needed?" In the logic of the new categories, they help distinguish Category B from C.

In the ambulance, sPESI can be calculated as additional information (it's quick: 6 variables, all clinical), but it's not the tool that helps you suspect PE — that's Wells/Geneva/PERC.

The correct logical sequence is:

1. Suspicion → Wells/Geneva + PERC (prehospital)
2. Diagnosis → D-dimer ± CTPA (ED)
3. Prognosis and setting → sPESI/PESI/Hestia + AHA categories (ED, post-diagnosis)

   ---

Operational flowchart "PE-Alert" (EMS/ED version)

Why a well-done "PE-Alert" really accelerates diagnosis

When the ED receives a structured pre-alert with scores, parameters, and motivated clinical suspicion, it can:

• Reduce the time between arrival and formal clinical suspicion — which in the non-pre-alerted patient can be 30–60 minutes or more
• Activate CTPA, ultrasound, and biomarkers early
• Prepare team and resources: advanced monitoring, possible PERT activation, surgery/interventional radiology alert
• Decide the care setting (ED, observation unit, ward, intensive care) with data already available

Classification into Categories A–E becomes operational only if the flow of information begins before hospital arrival. Without prehospital data, the Category is assigned with delay — and in PE, delay has a price.

Where EMSy can help

In this scenario — difficult suspicion, few minutes, incomplete data — a decision support tool can make a concrete difference:

• Guided clinical reasoning: EMSy's AI-Assistant knows the structure of the 2026 AHA guidelines and the concept of clinical categories A–E. It can support the clinician in differential reasoning and building suspicion.
• Integrated scores ready to use: Wells, Geneva, PERC for probability; sPESI, PESI, Hestia for prognosis and setting. All available in EMSy calculators, without having to remember variables and cutoffs by heart, reducing inter-operator variability.
• Standardized pre-notification: the "PE-Alert" structure can be generated with already collected data, transforming clinical suspicion into effective communication — which is often the real accelerator of the in-hospital pathway.

Take-home messages

For those working in EMS: your role is not to diagnose PE, it's to suspect it the right way and communicate it the right way. The new AHA categories give you a framework to describe what you see. Wells, Geneva, and PERC are your tools. The structured PE-Alert is your most valuable output.

For those working in ED: categories A–E are not an academic exercise — they're a common language to decide who to discharge (A–B), who to admit (C), who to monitor intensively (D), and who needs advanced therapies (D–E). PERT teams are recommended. Structured follow-up is an integral part of management, not optional.

For everyone: if you want to implement a "PE-Alert" in your service, the first step is not adding a test or buying an ultrasound. It's standardizing when to suspect, what to calculate, and how to communicate. The rest follows.

Main references:

• Creager MA, Barnes GD, Giri J, et al. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults. Circulation. 2026. DOI: 10.1161/CIR.0000000000001415
• Creager MA, Barnes GD, Giri J, et al. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults. JACC. 2026. DOI: 10.1016/j.jacc.2025.11.005
• Dudzinski DM, Cibotti-Sun M, Moore MM. 2026 Acute Pulmonary Embolism Guideline-at-a-Glance. JACC. 2026. DOI: 10.1016/j.jacc.2025.12.023